SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-010593
Filing Date
2023-03-29
Accepted
2023-03-29 16:06:39
Documents
12
Period of Report
2023-03-28
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K alec-20230328.htm   iXBRL 8-K 52910
  Complete submission text file 0000950170-23-010593.txt   170053

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20230328_lab.xml EX-101.LAB 13360
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20230328.xsd EX-101.SCH 2454
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20230328_pre.xml EX-101.PRE 9833
6 EXTRACTED XBRL INSTANCE DOCUMENT alec-20230328_htm.xml XML 4686
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 23775256
SIC: 2836 Biological Products, (No Diagnostic Substances)